These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1116102)

  • 1. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, HCG, three polyamines, and three minor nucleosides.
    Tormey DC; Waalkes TP; Ahmann D; Gehrke CW; Zumwatt RW; Snyder J; Hansen H
    Cancer; 1975 Apr; 35(4):1095-100. PubMed ID: 1116102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
    Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
    Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
    Tormey DC; Waalkes TP; Gehrke CW
    J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical markers in cancer of the breast.
    Tormey DC; Waalkes TP
    Recent Results Cancer Res; 1976; (57):78-94. PubMed ID: 796922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical correlation between CEA and breast cancer.
    Tormey DC; Waalkes TP
    Cancer; 1978 Sep; 42(3 Suppl):1507-11. PubMed ID: 709522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy.
    Levine L; Waalkes TP; Stolbach L
    J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer.
    Löser C; Fölsch UR; Paprotny C; Creutzfeldt W
    Cancer; 1990 Feb; 65(4):958-66. PubMed ID: 2297664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin.
    Waalkes TP; Gehrke CW; Tormey DC; Woo KB; Kuo KC; Synder J; Hansen H
    Cancer; 1978 May; 41(5):1871-82. PubMed ID: 647632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
    Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
    Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum spermine in breast cancer.
    Inamdar NA; Redkar SL; Mittra I; Damle SR
    Tumori; 1988 Apr; 74(2):171-6. PubMed ID: 3368971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyamine levels in gynecologic malignancies.
    Hayase R; Eguchi K; Sekiba K
    Acta Med Okayama; 1985 Feb; 39(1):35-45. PubMed ID: 3984779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyamine levels in blood and plasma of patients with malignant melanoma].
    Desser H; Kläring WJ; Luger T; Gebhart W
    Onkologie; 1982 Feb; 5(1):36-7, 40-1. PubMed ID: 7041033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective analysis of adenosine, 1-methylinosine and N2-methylguanosine by high pressure liquid chromatography.
    Brown PR; Krstulović AM; Hartwick RA
    Monogr Hum Genet; 1978; 10():135-40. PubMed ID: 723886
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum tumor markers in metastatic breast cancer and course of disease.
    Caffier H; Brandau H
    Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raised polyamines in erythrocytes from melanoma-bearing mice and patients with solid tumours.
    Takami H; Nishioka K
    Br J Cancer; 1980 May; 41(5):751-6. PubMed ID: 7426300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms.
    Gailani S; Chu TM; Nussbaum A; Ostrander M; Christoff N
    Cancer; 1976 Oct; 38(4):1684-6. PubMed ID: 991086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoembryonic antigen and other tumor markers in tissue and serum or plasma of patients with primary mammary carcinoma.
    Wahren B; Lidbrink E; Wallgren A; Eneroth P; Zajicek J
    Cancer; 1978 Oct; 42(4):1870-8. PubMed ID: 361213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.